32 Mutation in Human Immunodeficiency Virus (HIV)-seropositive and HIV- exposed Seronegative Individuals and in General Population of Medellin, Colombia

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug- resistance associated mutations in HIV-1 infected individuals

ation and management of dyslipidemia in human immuno- defi ciency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association

This study compares detection rates, genotype distribution and viral loads of different enteric viral agents in HIV-1 seropositive (n = 200) and HIV-1 seronegative (n = 125)

Risk factors associated with sexual transmission of HIV-1 infection in healthy individuals, HIV-1 exposed but uninfected individuals, HIV-1-infected asymptomatic, and patients

In order to assess the human immunodeficiency virus type 1 (HIV-1) drug resistance mutation profiles and evaluate the distribution of the genetic subtypes in the state of Rio

The occurrence of intestinal parasites, their regional distribution and their relations to eosinophilia were studied in 133 human immunodeficiency virus (HIV) positive individuals

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assess- ing subtype and drug-resistance associated mutations in HIV-1 infected individuals

The distribution of genetic polymorphisms of chemokine receptors CCR5- D 32, CCR2-64I and chemokine (SDF1-3’A) mutations were studied in 110 Human Immunodeficiency Virus type 1